Hackensack Meridian Health, Inc.

CIK 0001851813 · EDISON, NJ · Quarter end: 2026-06-30 · Filed on: 2026-08-05 · Open the SEC source

Hackensack Meridian Health, Inc. reported 7 positions worth $1.48B as of June 30, 2026 (13F filed August 5, 2026). Largest holding: SPY (35.7%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.48B
2026 Q2
Positions
7
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
7 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1SPYSPDR S&P 500 ETF TRSH$528.3M35.67%707,500
2EFAISHARES TRSH$293.4M19.81%2,823,932
3IEMGISHARES TRSH$186.1M12.56%2,246,000
4IWFISHARES TRSH$163.1M11.01%1,313,600
5EFVISHARES TRSH$160.8M10.86%2,101,000
6GNRSPDR INDEX SHS FDSSH$126.2M8.52%1,875,000
7ACWIISHARES TRSH$23.2M1.57%148,000

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Hackensack Meridian Health, Inc. hold as of Q2 2026?

Hackensack Meridian Health, Inc. reported 7 positions worth $1.48B in its Q2 2026 13F filing. Largest positions: SPY (35.7%), EFA (19.8%), IEMG (12.6%), IWF (11.0%) and EFV (10.9%).

What did Hackensack Meridian Health, Inc. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Hackensack Meridian Health, Inc. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.